TY - JOUR AU - Sayabovorn, Naruemit AU - Chongtrakool, Piriyaporn AU - Chayakulkeeree, Methee PY - 2021 DA - 2021/01/07 TI - Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review JO - BMC Infectious Diseases SP - 27 VL - 21 IS - 1 AB - Ruxolitinib is a novel oral Janus kinase inhibitor that is used for treatment of myeloproliferative diseases. It exhibits potent anti-inflammatory and immunosuppressive effects, and may increase the risk of opportunistic infections. Here, we report a rare case of Cryptococcus neoformans and Mycobacterium haemophilum coinfection in a myelofibrosis patient who was receiving ruxolitinib. SN - 1471-2334 UR - https://doi.org/10.1186/s12879-020-05703-2 DO - 10.1186/s12879-020-05703-2 ID - Sayabovorn2021 ER -